Background Heterologous vaccine regimens have been widely discussed as a way to
mitigate intermittent supply shortages and to improve immunogenicity and safety of COVID-19 …

Background Artemisinin-based combination therapy (ACT) for the treatment of malaria is
highly effective, well tolerated and safe. Episodes of delayed haemolysis occur in up to 57.9% …

BACKGROUND After its introduction as standard-of-care for severe COVID-19, dexamethasone
has been administered to a large number of patients globally. Detailed knowledge of its …

Using retinal organoid systems, organ-like 3D tissues, relies implicitly on their robustness.
However, essential key parameters, particularly retinal growth and longer-term culture, are still …

Objectives Dexamethasone has become the standard of care for severe coronavirus disease
2019 (COVID-19), but its virological impact is poorly understood. The objectives of this …

Protective antibodies against Plasmodium falciparum merozoite antigens, including EBA-175,
can inhibit erythrocyte invasion. New data from Musasia et al. indicate that these …

Highlights In a cohort of patients treated with oral artemisinin combination therapy for
uncomplicated malaria, the presence of anti-red blood cell (RBC) auto-antibodies does not …

We detected delayed and reduced antibody and T-cell responses after BNT162b2 vaccination
in 71 elderly persons (median age 81 years) compared with 123 healthcare workers (…

One week after second vaccinations were administered, an outbreak of B. 1.1. 7 lineage
severe acute respiratory syndrome coronavirus 2 infections occurred in a long-term care facility …

Purpose Six to 19% of critically ill COVID-19 patients display circulating auto-antibodies against
type I interferons (IFN-AABs). Here, we establish a clinically applicable strategy for early …